The Protein Problem: How Scaling Alternative Proteins Can Help People and Planet

Technology Policy Science & Innovation

The Protein Problem: How Scaling Alternative Proteins Can Help People and Planet

Paper
Posted on: 17th November 2021
By Multiple Authors
Karen Hooper
Policy Lead, Science & Innovation Unit
Hermione Dace
Policy Analyst

    Executive Summary

    Executive Summary

    Globally, 350 million tonnes of meat are produced every year, and that is only expected to increase. But growing concern about the impact of industrial meat production on climate change, demands for land use, ongoing food insecurity and demand for healthier food options are making this increasingly unsustainable. More and more people are looking for alternatives to meat.

    The global race to scale alternative proteins and plant-based and lab-cultivated meat – aka “meatless meats” – is on. The revolution in agriculture and food-production technologies presents an opportunity to diversify the way meat products are produced. And the countries that put strategies in place to leverage these innovations – like Singapore, the first country in the world to regulate cultivated meat – will be the ones to reap the economic, health and environmental rewards.  

    This doesn’t mean traditional reared meat should be off the menu, but harnessing the power of tech to create tasty alternatives gives more choice to consumers and helps to create a more sustainable solution to our protein problem.

    In this paper, we set out how governments with the political will can fix the protein problem, and enable the future food system to work better for people and planet.

    • In the short term, governments should encourage early-stage, discovery research and development both by providing policy support and funding grants to complement private-sector contributions.  
    • In the medium term, governments should support scale-up in production by investing in training and infrastructure, and updating regulations to encourage this evolving industry. 
    • In the long term, governments should ensure that alternative proteins are an element of an overarching plan for sustainability.

    Introduction

    Introduction

    With a global population predicted to reach 10 billion by 2050, figuring out a way to feed the world will be one of humanity’s biggest challenges. While over the past few decades, we have made progress in scaling up our global food production, it has become clear that the current way we produce food, particularly meat, is not sustainable. More and more evidence suggests that our growing demand for meat is a major contributor to many of our biggest global threats, such as climate change, biodiversity loss, zoonotic diseases and antimicrobial resistance, and these effects are compounding.

    While traditionally produced meat will always be on the menu, it is clear that we need to do something: if we are already grappling with the negative consequences of our current mode of production, what will happen as our population and demand for meat continue to grow?

    Despite – or perhaps because of – the scale of the challenge, too few governments have strategies in place to address this issue. Encouraging mass behaviour change can be politically unpalatable, and up until recently, there has been a lack of feasible alternatives.

    Fortunately, recent innovations in agriculture and food technologies present a chance to diversify our sources of protein with more sustainable products like plant-based, microorganism-based and cultivated meat. By leveraging these technological breakthroughs, we can dramatically alter our current industrial model of production, enabling our future food system to work better for both people and planet.

    By supporting the development and sale of alternative proteins, governments can help significantly reduce the negative impact of traditional meat production, while promoting consumer choice and creating thousands of new green jobs. In the UK, for example, investing in alternative proteins can simultaneously help the country meet some of its key policy objectives in relation to the environment, public health and the economy. Addressing our protein problem shouldn’t just be seen as an issue to be solved – it should also be viewed as an opportunity for countries to embrace.

    Some governments are already recognising the opportunities presented by alternative proteins. Last year, Singapore became the first country in the world to authorise cultivated meat. More recently, the United States Department of Agriculture (USDA) has announced it will fund its own flagship cultivated-protein research centre. And in the UK, the recent National Food Strategy identified the adoption of alternative proteins as a key part of the transition the country needs to make.

    But for these products to make a significant impact at the scale we need, the speed of innovation needs to dramatically increase. In order for the UK and other countries around the world to capitalise on the opportunities of alternative proteins, policymakers will need to ramp up research and development, encourage better regulation and more appetite for risk, and invest in skills and training.

    In this report, we explain why the way we currently produce meat puts the future of our planet and humanity at risk, and how scaling alternative proteins offers the best opportunity to fix our protein problem. Consumer demand for these products will only increase, so the actions governments take now can help determine how quickly alternative proteins gain both popularity and viability. And early adopters will capture the economic and environmental benefits.

    Issues at Steak: Why We Must Act

    Issues at Steak: Why We Must Act

    Globally, we consume around 350 million tonnes of meat a year. To put that in context, there are now around three chickens for every human on the planet, and livestock outweighs wild mammals and birds by a factor of ten.

    These figures are expected to grow as incomes rise and urbanisation increases; meat and seafood consumption is expected to rise by 78 per cent by 2050 in Asia alone.

    If meat consumption does continue to increase at this rate, then even with efficiency improvements we may run out of land on which to produce it. But land use is not the only problem created by our appetite for meat – its production also contributes to global emissions, deforestation, the loss of biodiversity, antibiotic resistance and food insecurity, while increasing the likelihood of zoonotic diseases and pandemics.

    There are, in fact, few other human activities that present such a risk to our planet and the future of humanity itself. Leaders can no longer afford to ignore our global meat problem.

    Figure 1 – The protein challenge and its associated impacts

    Source: TBI analysis

    Our Options

    Our Options

    We could simply eat less meat; reducing the amount of meat produced and consumed would address many of these health and environmental concerns and has been suggested in numerous policy reports. Unfortunately, the reality is not so straightforward. First, who should reduce their consumption and how would such a policy be implemented? In low-income countries, the amount of meat and dairy consumed is lower, but as these countries tend to have greater food insecurity, is reducing access to any sources of nutrients a reasonable ask? Is it fair to tell these countries that they shouldn’t strive to have the same standard of living as countries that have long enjoyed unbridled consumption? And what would the economic impact be on developing markets where meat exports are responsible for a significant percentage of the job market and GDP? Even within developed markets, the same questions around fairness apply – food insecurity is also an issue among lower-income families. There’s also the political reality: outside voluntary personal measures, the idea of regulating meat consumption is overwhelmingly viewed unfavourably in both high-and low-income markets.

    Another option could be to improve the way we currently produce animal products, including management of livestock diet and manure. A number of technical improvements have already been developed: changes in animal feed and selective breeding have shown potential for improvements in both productivity and emissions reductions; improvements in technology allow for better control of health monitoring (with downstream effects for human health); and anaerobic digestors allow manure to be converted into bio-gas, an energy source that can be used to create fuel and electricity or power farm machinery. While these all sound promising, the reality is, again, challenging.

    Many of these improvements will only be significant if scaled. The cost of implementation varies widely, and some of these innovations may be difficult or undesirable to implement among smallholder farmers in Africa and Southeast Asia, where livestock often serve multiple purposes outside of providing food, such as storing wealth, and whose contribution is roughly a third of total global livestock emissions. Even if the cost can be brought down, there may be little incentive to change – why should meat producers take on the risk of investing in new tools and techniques? And even if these improvements can be scaled, research suggests the emissions reductions from implementing all these technical innovations will still not be enough to keep us on a 1.5 degree pathway.

    Eating less meat is a good idea for many reasons, and softer policies designed to encourage this behaviour can and should be implemented. Similarly, any way to improve the production of animal products and meat, and the lives of those producing it should be investigated, at the very least. However, while they may work as short- or medium-term solutions, neither are going to address all the issues at stake or drive enough of the change needed in the long term. So where does this leave us?

    Making Alternative Proteins a Political Priority

    Making Alternative Proteins a Political Priority

    Innovations in alternative proteins have skyrocketed in the past few years, and present an exciting opportunity to “have our steak and eat it, too”. While non-meat protein sources such as tofu have always been a staple in some cultures, new discoveries in creating, harvesting and processing plant-based, cellular-based and microorganism-derived alternatives have created products that increasingly resemble traditional meat in all aspects. But these alternative proteins have more to offer than just resembling or replacing meat; they have the potential to address all the issues at stake, which is why focusing on scaling alternative proteins must be a political priority for countries, rather than something just the private sector explores.

    From a sustainability point of view, a report from the Good Food Institute (GFI) and policy and research group Climate Advisers finds that production of alternative proteins uses less water and less land, reducing deforestation and freeing up space for regenerative agriculture and biodiversity protection. The report also notes that reducing livestock numbers naturally reduces emissions of the greenhouse gases, methane and nitrous oxide released directly from cows. While there are uncertainties around how energy-intensive scaling up the production of alternative proteins will be, these questions are already being addressed in the overall conversation around renewables.

    In terms of health, because there is far less, if any, contact with live animals, the production and consumption of alternative proteins would largely reduce overall zoonotic and antibiotic-resistance risks. As with sustainability, there are still many questions we need to answer about the health impact of alternative proteins, but we can’t know what risks there are – or even if any exist – without more research.

    Finally, there is an argument for employment and economic stability. Technology has upended many industries and jobs in the past few decades, and alternative proteins are likely to disrupt the current agricultural industry through labour displacement and loss of revenue from traditional sources. But shifts in demographics, geopolitics and climate change are already pushing us in this direction: agriculture currently represents a huge proportion of the workforce – employing around 1 billion people globally – but thanks to increasing urbanisation, far fewer people work on the land today than ever before. In 1900, around 41 per cent of America’s labour force worked on a farm; now the proportion is below 2 per cent.

    Meanwhile, in Britain, Brexit is making it difficult for farms to access labour from Europe, strengthening the case for increased automation and higher-tech farming methods. It’s also increasingly likely that traditional farming will become less sustainable as farmers find it harder to make a profit in the face of severe weather, climate change and declining soil fertility.

    Similarly, the impact of climate change on traditional farming poses a threat to food security. Alternative proteins provide a means to ensure access to key nutrients even if a country’s natural resources traditionally have not been able to support domestic-food production, for example small, densely-packed urban nations or countries where the environmental conditions make it difficult to grow crops or rear livestock.

    Given all these factors, policymakers will have to address the future of the farming industry at some point, and alternative proteins present an opportunity. The high level of investment – $3.1 billion dollars in 2020 – and explosion of companies is a signal from the private sector that this is a fast-growing industry with potential to create new jobs that are both green and secure. Countries that invest in the research and development (R&D), training and infrastructure to scale the fastest will capture the biggest slice of the market and will reap the most economic rewards.

    Case Study: The Benefits of Alternative Proteins for the UK

    Building up a domestic alternative-protein industry should not just be a response to the challenges presented by traditional meat consumption. It also presents a major opportunity. In the UK, investing in alternative proteins can simultaneously help the country meet some of its key policy objectives in relation to the environment, public health and the economy.

    Figure 2 – Focusing on alternative proteins also helps achieve several key UK policy aims

    Environmental

    Health

    Economic

    Other

    Achieve net zero by 2050 and keep the global-warming target limit set out in the Paris Agreement of between 1.5°C–2°C within reach.

    The Climate Change Act, as amended in 2019, commits the UK to net zero by 2050.

    Emissions from UK livestock account for around 5.5 per cent of the country’s total greenhouse-gas emissions. Alternative proteins can help cut food-related greenhouse gas emissions significantly. Currently, two of the most innovative plant-based burgers on the market produce 89 per cent less greenhouse gases than conventional beef burgers.

    Contain and control antimicrobial resistance (AMR) by 2040

    In 2019 the UK government launched a five-year action plan and 20-year vision for containing and controlling AMR. This includes reducing antibiotic use in animals.

    One major cause of antibiotic resistance is the use – or overuse – of antibiotics in farm animals. Over 70 per cent of all antibiotics are used for conventional animal agriculture. Producing alternative proteins removes the need for animals, so also reduces the need for antibiotics.

    30 by 30: Protect 30 per cent of land for nature by 2030

    Set out in the UK government’s 25-year Environment Plan, this strategy involves creating or restoring 500,000 hectares of wildlife-rich habitat and increasing woodland in England.

    Around 70 per cent of land in England is used for agriculture. A staggering 22 per cent alone is used to grow livestock feed. Some studies show that cell-based beef could reduce the impact of livestock production on land use by more than 95 per cent. Much of this spared land could be used to increase woodland, rewild and promote biodiversity.

    A green industrial revolution

    A green recovery from the pandemic – with high-skilled, high-paid jobs that make our nation both cleaner and greener.

    The National Food Strategy states that the UK’s alternative-protein industry has the potential to create up to 10,000 new manufacturing jobs as well as support in the retention of 6,500 farming jobs. Alternative proteins could also present an export opportunity if the UK gets ahead of the curve.

    An action plan for animal welfare

    The 2021 Action Plan for Animal Welfare attempts to position the UK as a world leader on animal welfare and states an ambition to put animal welfare at the very heart of government policy decision-making.

    Although not currently on the government’s radar when it comes to promoting animal rights, producing protein from plants or in labs removes animals from the equation completely, meaning there is no risk of harming them.

    International pandemic-preparedness initiative

    The UK government has launched a pandemic-preparedness partnership both to save lives from future new diseases and to prevent another global pandemic.

    The United Nations Environment Programme has found that one of the most likely causes of the next pandemic is animal-protein production. Reducing traditional animal-protein production could play a role in helping to prevent another pandemic.

    Source: TBI analysis

    Rate of Advancement: How Fast Can We Scale?

    Rate of Advancement: How Fast Can We Scale?

    Winston Churchill was perhaps overly optimistic when he imagined the world 50 years on from the 1930s and wrote: “We shall escape the absurdity of growing a whole chicken in order to eat the breast or wing by growing these parts separately under a suitable medium.” Still, the rate of development of alternative protein products has advanced rapidly. Plant- and microorganism-based proteins have benefited from a steep rise in funding alongside a decrease in the cost of production. Products from plant-based companies such as Beyond Meat and Impossible Foods are already in supermarkets and restaurants, and increasingly popular, with sales growth double that of overall food sales in the past year.

    Even the most technically challenging product, cultivated meat, has developed quickly: the first cultured burger was created and eaten in 2013, and seven years later, Singapore became the first country to give regulatory approval for lab-grown meat to be sold commercially.

    Other cultivated meat products like chicken and seafood, more complex cuts of meat such as steak, and even dairy products have also been developed in roughly the same timeframe, aided by the falling costs of production and increased levels of funding. The cost for producing the first cultivated hamburger was around $1.2 million per pound, whereas in late 2020 it was hovering close to $50 per pound, less than .005 per cent of the initial cost. Investment has increased significantly as well, from $6 million in 2016 to $366 million in 2020 – or an increase of over 6,000 per cent.

    Figure 3 – Investment and deals in cultivated meat

    Source: GFI analysis of PitchBook data

    The rapidly increasing pace of innovation is not unique to alternative proteins; similar observations have been made in other tech sectors, most famously captured by Gordon Moore’s eponymous law on the number of transistors and decreasing cost of microchips. Playing on this concept, Agronomics’ Jim Mellon titled his recent book Moo’s Law; he estimates that within the next ten years, 50 per cent of all meat consumed will either be cultivated or plant-based. We are similarly optimistic – aside from increased funding and decreased cost of production, predictions often underestimate change (for a case in point, look at renewable energy) – but this is dependent on overcoming a few obstacles.

    Barrier to Scaling: Reaching “Griddle Parity”

    Cost is the biggest factor affecting our ability to scale alternative proteins and the rate at which we can do so. To lower costs, the efficiency of sourcing, processing and production will need to improve, which will require major investments across the value chain. For cultivated meat, sourcing is a major bottleneck: access to cell lines and the medium in which animal cells need to grow are hard to come by and expensive. Cells need a special cocktail of nutrients, hormones and growth factors, which can come from a variety of sources. Most producers of cultivated meat use foetal bovine serum (FBS) as their source of micronutrients, which can cost up to $2,000 a litre. Additionally, the overhead costs of the facilities required to produce cultivated meat at scale are significant: much of the equipment is custom-created and requires precautions to ensure that the environment is sterile. To have enough supply to reach 10 per cent global market share by 2030, estimates based on one techno-economic assessment indicate that 4,000 facilities, housing 130 bioreactors, at a cost of $1.8 trillion are needed. While there are many economic challenges, the high levels of interest and investment in the alternative-protein space are already starting to drive costs down. Led by Professor William Chen, director of Nanyang Technological University (NTU)’s Food Science and Technology programme, a team of Singaporean researchers have shown that FBS can be replaced by fermented okara, a by-product generated from the creation of tofu and soy milk. This is not only more sustainable than FBS but, at $2 a litre, also significantly cheaper.

    There are similar efficiencies that can bring the cost down for plant and microorganism-based proteins, though overall they are much less costly and closer to price parity. A survey of experts from Boston Consulting Group (BCG) found that for plant-based products, cost reduction is likely to result from improved crops, formulation and texturising, and for microorganism-based proteins from improvements in sourcing and growth conditions. According to Moo’s Law, “griddle parity” (a spin on grid parity – the point at which the cost of renewables is the same as or less than conventional energy from the grid) is expected to be reached in five to ten years, starting with plant-based options. Most other predictions are in agreement: BCG estimates cost parity for all alternative proteins by 2032.

    Figure 4 – General steps for alternative-protein creation

     

    Sourcing

    Processing

    Production

    Cultivated

    Sourcing

    • Stem cells obtained: primary (animal tissue) or "immortalised" (embryonic or induced pluripotent)
    • Cell sorting and placement in culture medium

    Processing

    • Put in bioreactor to grow and differentiate at scale
    • Exploration of scaffolds for structure

    Production

    • Harvested; additional ingredients for taste and/or consistency
    • Exploration of 3D printing to print specific cuts

    Plant

    Sourcing

    • Ingredients sourced (e.g., pea, soy)

    Processing

    • Protein isolated
    • Additives for taste, aesthetics
    • Extrusion for texture

    Production

    • Shaping

    Microorganism

    Sourcing

    • Ingredients sourced (e.g., fungi)

    Processing

    • Growth in fermentation tanks
    • Traditional: process and modify plant-based
    • Precision: "factory" to produce ingredients
    • Biomass: scale to create product

    Production

    • Shaping, drying
    • Additives for taste, aesthetics
    • Used as standalone product for food, ingredient or animal feed

    Source: International Journal of Molecular Sciences; HK Centre for Food Safety

    Barrier to Scaling: Regulatory Headwinds and the “Ick” Factor

    Globally, regulatory processes around alternative proteins are often opaque and slow, hindering a clear path to commercialisation. Food regulatory bodies’ emphasis on evaluating individual health risks means that broader societal and environmental benefits are often not taken into account. Cultivated-meat approval is particularly daunting: Singapore remains the only country in the world to have approved its sale.

    In many countries, labels have become a drawn-out legal battle. The US and EU have been divided over the use of terms such as “sausage” and “steak” for plant-based proteins. While the EU recently voted to allow use of the term for plant-based meat alternatives, a ban on using traditional dairy terms for plant-based dairy alternatives was passed, and additional proposals with different restrictions have been submitted. Texas passed a bill earlier this year prohibiting producers of plant-, insect- or cell-based proteins that do not contain meat from slaughtered animals, from using terms like “meat”, “beef” or “poultry product”. Labels are important because research shows that framing is extremely important for consumer acceptance. Food neophobia – the fear of new things – is a key predictor of cultivated-meat rejection across the Americas, Europe and Asia, so familiar names and products that are prepared and served in a familiar way – hamburgers, for instance – are much more likely to convince more hesitant swathes of the population. Similarly, various studies have found that consumer perceptions are impacted by the names given to cultivated meat: references to “synthetic”, “lab-grown” or “cell-based” meat have been found to be less appealing than labels such “cultivated” or “clean”. In general, more technical descriptions tend to evoke associations with unnaturalness and safety, the top concerns around alternative proteins.

    Taste and texture will also be key factors in the sustained consumption of alternative proteins. Many products are getting close – this is the primary area of focus for many startups – but replicating the real thing often requires significant amounts of processing and additives, which raises questions around the impact of alternative proteins on health. The large sums of money invested (or the prospect of investment) can create an added pressure for startups to withhold the exact details about how they create their products: in typical tech funding, proprietary techniques, models or innovations are used to justify high amounts, and the details are fiercely guarded. To similarly justify the high levels of funding, food-tech companies may also be hesitant to share their exact processes and ingredients. While it is fair for investors and entrepreneurs who have placed a lot of resources into food research to reap the commercial rewards – this is a major driver of innovation, after all – transparency in food is a public-health and safety concern. There must be some level of involvement from the government to protect consumers.

    Where Are We Now? The Global Race for Alternative Proteins

    Where Are We Now? The Global Race for Alternative Proteins

    To date, the boom in alternative proteins has mostly been driven by the private sector. Some governments around the world now recognise the importance of supporting the alternative-protein industry. However, few countries have comprehensive strategies to scale alternative proteins, and globally there has been a lack of policy put forward to support the industry, despite its potential benefits to the environment, economies and human health.

    Investment and policy support are particularly underwhelming when compared to those enjoyed by other strategic sectors that are essential for net zero. For example, the UK government has announced it will invest at least £265 million in offshore wind per year – a sharp contrast to the £90 million Research and Innovation programme put forward to transform food production, of which alternative-protein projects merely form a part.

    As countries including China win some crucial battles by throwing their weight behind many key tech sectors, and Singapore and Israel shoot ahead in developing their alternative-protein sectors, other countries, like the US and UK, risk falling behind.

    Figure 5 – Leaderboard of countries encouraging alternative-protein development

    Country/region

    Regulatory landscape

    Investment/funding

    Other policy support

    Singapore

    • Commercial sale of cultivated meat approved in December 2020
    • Commercial cultured-meat production facility approval July 2020

    $144 million

    • Has established itself as the epicentre of alternative proteins by encouraging global food corporations to establish R&D centres, new product-development facilities and pilot projects

    Qatar

    • Expected to approve cultivated meat for sale imminently

    N/A

    N/A

    Israel

    • Cultivated meat not approved
     
    • Israel has emerged as a hub for alternative-protein innovation. It has a National Policy Plan – a detailed roadmap for making Israel the global alternative-protein leader
    • The Israel Innovation Authority has established foodtech incubators

    Netherlands

    • Cultivated meat not approved
     
    • Has a protein cluster as part of its “Food Valley”, bringing together firms to drive plant-protein innovation
    • Home to several alternative-protein research centres, accelerators and companies

    US

    • Cultivated meat not approved
    • In 2018, the USDA and the FDA announced their intent to implement a joint regulatory framework for cultivated meat

    $10 million

     

    Canada

    • Cultivated meat not approved
    • FAIRR report regulation…

    $252 million

     

    Australia

    • Cultivated meat not approved
       

    UK

    • Cultivated meat not approved
    • Will benefit from £90 million UKRI funding
     

    China

    • Cultivated meat not approved
     
    • Recently announced a five-year plan that includes cellular and genetic-food technologies

    Japan

    • Cultivated meat not approved

    $2.2 million

    • In April 2020 the Ministry of Agriculture, Forestry and Fisheries launched the Food Tech Research Group. It aims to foster the food industry and strengthen Japan’s food security through technology

    EU

    • Cultivated meat not approved

    $49.7 million

    • The EU’s Farm to Fork project includes a three-part research programme on alternative proteins

    Sources: Good Food Institute, Social Market Foundation, FAIRR

    Recommendations

    Recommendations

    Short Term: Support Early-Stage R&D and Increase Access to Information

    The GFI grant tracker shows that of $112 million in alternative-protein grants globally, roughly $75 million comes from governments, and only 39 per cent of those grant dollars have been awarded to research that produces publicly accessible results. Split by selected regions, we can see a huge variety in grants, with a higher number of government-funded grants in Singapore, non-profit-led grants leading in the US, and the private sector dominating in Germany. Government grants complement private-sector contributions to provide funding for basic R&D that may not lead to a near-term commercial product, but is nonetheless essential to the industry’s progress, to providing objective research to ensure that any concerns that surface are addressed and to ensuring that results are accessible to a wider audience.

    Figure 6 – Number of R&D grants by funder country and type

    For context, our leaderboard frontrunner, Singapore, has invested in this space through a number of initiatives: for example, $144 million through the Research Innovation Enterprise 2020 Plan and $90 million through SEEDS Capital, the investment arm of Enterprise Singapore; sovereign wealth fund Temasek has invested $5 billion in the agrifood space over the past five years, with a significant portion in alternative proteins.

    Medium Term: Scale Up Production

    • Support training: The development and production of alternative proteins will require new skills, but courses are few and far between. Government support for training will speed up talent development to attract and scale companies – as well as help traditional workers, like livestock farmers, to transition. Partnering with private or public organisations like the GFI, which has created a publicly accessible curriculum to support faculty and instructors, governments can set up training institutes or subsidise courses. For example, Singapore’s SGUnited Skills programme is designed to help Singaporeans acquire in-demand skills in emerging sectors, including food tech. Under this programme, jobseekers receive subsidised training through courses designed in partnership with the industry and delivered by special training centres, a monthly stipend, and placement support if needed, while firms are offered a hiring incentive to take on workers who have participated in a training scheme.

    A New Generation of Food Science: Talent Development

    Professor William Chen is the Michael Fam Chair Professor in Food Science & Technology at Nanyang Technological University (NTU) and Director of the Food Science & Technology Programme, an integrated Education–Research–Innovation platform. In partnership with GFI, he is coordinating a new course for science and engineering students with a major in Food Science and Technology at NTU, one of the top schools in Asia.

    “Talent development is important for the sustainability of the novel food system. The new elective course jointly offered by GFI APAC and NTU on Future Foods – Introduction to Advanced Meat Alternatives – plays an important role in preparing talent for the novel food system. Unlike other classroom courses, this alternative-protein course is designed to develop problem-solving skills in our young university students. Following learning the fundamental aspects of alternative proteins, students are divided in smaller groups to work on problem statements from current industry stakeholders in the alternative protein space, and propose solutions, very much like an Open Innovation Challenge. We are hopeful that creativity for innovations can be unlocked from our students through this new course, which in turn would contribute and sustain the development of the alternative-protein industry.”

    • Invest in infrastructure: Producing alternative proteins at scale is costly, as it usually requires hard-to-source ingredients as well as expensive specialised facilities and tools. For example, bioreactors are needed to grow cultivated meat, but those currently available were developed to produce high-price-per-unit pharmaceuticals. To make cultivated meat more cost-effective, more commercially viable high-volume bioreactors need to be developed. Supporting infrastructure either through subsidies or the creation of central facilities could lower costs until demand grows large enough. Singapore has created FoodInnovate, a multiagency initiative to help build capabilities, provide resources and enable partnerships in the food-production space through innovation. Through this type of initiative, companies can access facilities, experts and partners more easily. In addition to assisting with physical infrastructure, policymakers can help vendors scale by facilitating cooperation and standards-setting, as with the semiconductor and wireless industries. Standards-setting can also help with other public-policy goals, such as enabling more companies to compete, and thus influencing the pace of innovation and cost.
    • Update regulation to scale innovation and build trust: While startups face a lagging regulatory environment, consumers may be concerned about the safety and sustainability of alternative proteins. Updates to regulation can help on both fronts: streamlining the path towards approval and thus commercialisation would send an encouraging signal to companies and investors, while consistent standards and objective government evaluation would encourage consumer acceptance. Singapore is, again, a leader in this space: to accelerate food-safety research, support food-science capabilities and enable regulatory responsiveness to speed up the commercialisation of novel foods, Singapore has created a tripartite initiative, FRESH. In addition to a more streamlined and transparent process, we also recommend policymakers rethink their overall approach to how alternative proteins are evaluated, ensuring both health and environmental risks and benefits are taken into account.

    Long Term: Nurture a Sustainable Ecosystem

    • Set a clear vision: To scale alternative proteins, policymakers will need to define their long-term vision and set a series of targets. But taking a holistic view is important: while investments and training schemes will address the specific challenges of alternative proteins, these policies must be developed and implemented alongside progress in parallel areas such as renewable energy and waste management. For both Singapore and the Netherlands, the scaling of alternative proteins is one element of an overarching plan for sustainability. Policymakers need to be wary of conflicting policy goals: trying to scale alternative proteins while simultaneously giving the livestock industry large subsidies sends mixed messages and makes it difficult for alternative proteins to achieve price parity.
    • Work with stakeholders: The cooperation of stakeholders is crucial to the success of any of these policies. Asking for and receiving feedback from multiple levels – from grassroots-community leaders to industry organisations – will help ensure these policies are relevant and appropriate. It will also help to address concerns related to job and industry viability, which have been flashpoints in the US and the EU. This can be done through consultation with community leaders or industry groups, or even by engaging the general public. The US Department of Agriculture, for example, is currently seeking comments on what to name and how to label cell-based meat in the US.

    Leveraging the UK’s existing advantages

    For the UK, setting out the regulatory and commercial pathways for cultivated meat approval is crucial. To maintain competitive advantage post-Brexit and fulfil its goal of being at the forefront of global innovation, the UK must facilitate an environment for researchers and startups to capitalise on their pioneering innovations.

    In a great first step, the UK recently relaxed the requirements for field research on gene-edited crops. However, the change did not specify a path to market. This is hugely disincentivising for many researchers, and even those who do continue to develop ground-breaking innovations in the UK could see those techniques commercialised in other nations who have responded more swiftly, resulting in these UK-based innovators losing out on jobs (the National Food Strategy suggests that 10,000 factory roles and 6,500 farming jobs can be created through expansion of the alternative-protein industry), benefits and profits.

    By clearing a pathway, the UK can leverage its existing advantages – universities that are already leaders in alternative-protein research, its strength in the petrochemical and pharmaceutical industries, which utilises similar techniques to alternative-protein production, and the scale of its domestic market – to become a leader in this industry and an attractive location for commercial investors.

    Conclusion

    Conclusion

    From an environmental, health-focused and economic point of view, meeting the rising demand for meat in our current manner of production comes at too high a cost and the solutions won’t come from turning back the clock. Fortunately, we don’t have to: new advances in alternative proteins can help us do better for the environment, our health and our society if we have the courage to seize the opportunity.

    Countries who invest in and devise policies to advance alternative proteins will find themselves ahead of the curve, becoming world leaders in reducing emissions from agriculture, increasing food security, protecting human health and promoting biodiversity. The countries who move quickly will also have most to gain from an export market of alternative proteins as global demand increases.

    We would like to thank all those who helped inform this paper, and particularly acknowledge Prof. William Chen, Director of Nanyang Technological University’s Food Science and Technology Programme, who reviewed drafts.

     

     

     

    Lead Image: Getty Images

    Charts created with Highcharts unless otherwise credited.

    Find out more
    institute.global